Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/296952
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Pleiotropic biological effects of Lupinus spp. protein hydrolysates |
Autor: | Cruz-Chamorro, Iván CSIC ORCID; Santos-Sánchez, Guillermo CSIC ORCID; Álvarez-López, Ana Isabel CSIC ORCID; Pedroche, Justo CSIC ORCID ; Lardone, Patricia Judith CSIC ORCID; Arnoldi, Anna; Lammi, Carmen; Carrillo-Vico, Antonio CSIC ORCID | Palabras clave: | Bioactive compounds Hydrolysates Interleukin LDL-R Nutraceuticals Oxidative stress |
Fecha de publicación: | 1-mar-2023 | Editor: | Elsevier | Citación: | Trends in Food Science and Technology 133: 244-266 (2023) | Resumen: | Background: Over the last two decades, the demand for meat-free food has increased for health, environmental, and animal welfare reasons. Thus, research on the value of vegetable compounds as beneficial agents for human health has gained much attention. In particular, great interest has been shown in protein hydrolysation since this food technology facilitates the release of encrypted peptides with biological activities. In this sense, during the last 10 years, the biological activities of Lupinus spp. protein hydrolysates (LPHs) have been extensively studied. Scope and approach: The aim of this review is to address all studies (in silico, in vitro, and in vivo) in which the biological activities (antioxidant, anti-inflammatory, etc.) of LPHs were described, both the whole hydrolysate and the derived peptides. Moreover, the physicochemical characteristics of LPH peptides are evaluated, and challenges and future perspectives for their fast application have been discussed. Key findings and conclusions: LPHs exert many important biological effects in both the in vitro and in vivo systems. The main activities of LPHs described are antioxidant, immunomodulatory, hypotensive, hypoglycemic, and hypolipidemic. These findings point to LPHs as a possible new nutraceutical for human health, capable of preventing or treating some chronic diseases such as diabetes, dyslipidemia, and atherosclerosis. Finally, the development of a new generation of nanonutraceuticals to improve the metabolic stability and bioactivity of LPHs has been discussed. | Descripción: | 23 Páginas.-- 4 Figuras.-- 4 Tablas | Versión del editor: | https://doi.org/10.1016/j.tifs.2023.02.011 | URI: | http://hdl.handle.net/10261/296952 | DOI: | 10.1016/j.tifs.2023.02.011 | ISSN: | 0924-2244 |
Aparece en las colecciones: | (IG) Artículos (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
TFST_2023_V133_P244.pdf | Artículo principal | 6,12 MB | Adobe PDF | Visualizar/Abrir |
TFST_2023_V133_P244_MatSup.pdf | Material suplementario | 581,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
5
checked on 23-abr-2024
WEB OF SCIENCETM
Citations
3
checked on 26-feb-2024
Page view(s)
46
checked on 28-abr-2024
Download(s)
29
checked on 28-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Este item está licenciado bajo una Licencia Creative Commons